Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 16/20 | 1.00 |
| ▸ | FNTB | P49356 | 16/20 | 1.00 |
| ▸ | PGGT1B | P53609 | 10/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14175665 | 0.91 | FNTA (0.84) | FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL14169145 | 0.89 | FNTA (0.80) | FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL8750304 | 0.85 | FNTA (1.00) | FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL16136603 | 0.80 | FNTA (0.67) | FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL8097481 | 0.80 | FNTA (0.67) | FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL8623007 | 0.80 | FNTA (0.67) | FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL10038916 | 0.80 | FNTA (0.67) | FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL2324069 | 0.78 | FNTA (0.62) | FNTAFNTB | |
| SCHEMBL9828951 | 0.78 | FNTA (0.62) | FNTAFNTB | |
| SCHEMBL8626782 | 0.77 | FNTA (0.82) | FNTAFNTBPGGT1BTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0764149-A1 | NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | Aventis Pharma S.A. (FR) | 1997-03-26 | — | — | EP | disclosed |
| WO-1995034535-A1 | NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | RHONE-POULENC RORER S.A. (FR) | 1995-12-21 | — | — | WO | disclosed |